Amphastar Pharmaceuticals Stock News

Amphastar (AMPH) delivered earnings and revenue surprises of 10.53% and 8.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q4 2021 Earnings Call Transcript

Amphastar Pharmaceuticals press release (AMPH): Q4 Non-GAAP EPS of $0.42 beats by $0.05.Revenue of $120.9M (+26.0% Y/Y) beats by $9.28M.

Amphastar (AMPH) delivered earnings and revenue surprises of 10.53% and 8.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

RANCHO CUCAMONGA, CA / ACCESSWIRE / March 3, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2021 ended December 31, 2021

We identified 18 stocks in S&P 500 with strong momentum based on our criteria. Ten of the stocks we identified made new all-time highs.

When markets that have flown so high for so long start to tumble, along with an economy that transitioning, safe stocks are essential. The post 7 Safe Stocks to Rely On When the Market Swerves appeare

Amphastar Pharmaceuticals Inc (AMPH) shares closed today at 0.8% below its 52 week high of $26.49, giving the company a market cap of $1B. The stock is currently up 7.5% year-to-date, up 31.3% over the past 12 months, and up 56.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.1%, and the S&P 500 fell 0.6%. Trading Activity Trading volume this week was 24.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -128.8% The company's stock price performance over the past 12 months beats the peer average by -151.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Amphastar Pharmaceuticals Inc (AMPH) shares closed today 11.4% lower than it did at the end of yesterday. The stock is currently up 11.9% year-to-date, up 43.3% over the past 12 months, and up 71.3% over the past five years. Today, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.8%. Trading Activity Shares traded as high as $26.49 and as low as $22.07 this week.Shares closed 11.5% below its 52-week high and 36.5% above its 52-week low.Trading volume this week was 143.9% higher than the 10-day average and 157.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -142.1% The company's stock price performance over the past 12 months beats the peer average by -176.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Amphastar Pharmaceuticals Inc (AMPH) shares closed 0.7% higher than its previous 52 week high, giving the company a market cap of $1B. The stock is currently up 7.5% year-to-date, up 32.9% over the past 12 months, and up 60.7% over the past five years. This week, the Dow Jones Industrial Average fell 1.6%, and the S&P 500 fell 3.5%. Trading Activity Trading volume this week was 43.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 3.9% higher than its 5-day moving average, 5.8% higher than its 20-day moving average, and 22.8% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -123.7% The company's stock price performance over the past 12 months beats the peer average by -157.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Amphastar has a unique combo of a development stage and a more mature biotech company. It is well placed in growing but competitive areas of medicine like diabetes and asthma.

Amphastar Pharmaceuticals Inc (AMPH) shares closed today at 1.9% below its 52 week high of $25.87, giving the company a market cap of $1B. The stock is currently up 8.9% year-to-date, up 35.7% over the past 12 months, and up 47.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 6.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -171.5% The company's stock price performance over the past 12 months beats the peer average by -175.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Amphastar Pharmaceuticals Inc (AMPH) shares closed today at 1.9% below its 52 week high of $25.87, giving the company a market cap of $1B. The stock is currently up 7.0% year-to-date, up 28.5% over the past 12 months, and up 45.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 7.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -148.1% The company's stock price performance over the past 12 months beats the peer average by -156.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.